Delivery Order SPE2DB22D1002-SPE2DB25FLCJ7

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Menveo A-C-Y-W Kits (2 vials) to the Defense Logistics Agency (DLA). The contract, valued at $1,542.20, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
This federal contract award is a delivery order for the procurement of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies, valued at $4,343.90. The award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and an ultimate completion date of November 8, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,161.25 and an ultimate completion date of September 25, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating it was...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract, valued at $3,860.28, to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MENVEO A-C-Y-W KIT (2 VIALS), a vaccine product, with a period of performance through April 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to...
This federal contract award is a delivery order valued at $37,825.20 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with an ultimate completion date of May 28, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,122.83 firm fixed-price delivery order is for the supply of MENVEO A-C-Y-W kits (2 vials) and has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a wide range...
This federal contract award is for the delivery of pharmaceutical products and medical supplies, specifically MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $12,955.78 and an ultimate completion date of November 17, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract...
This federal contract award is for the delivery of Menveo A-C-Y-W Kits (2 vials) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 7, 2024, with a completion date of November 8, 2024. The contract has a ceiling value of $1,286.76 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,251.83 contract is for the provision of 4563797875 - MENVEO A-C-Y-W KIT (2 VIALS)S, with a performance period through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. This order is issued under...
This is a $1,342.88 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies, with a performance period ending on May 22, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLCJ7
    Delivery Order

This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) to the Defense Logistics Agency (DLA), a defense agency. The $3,692.92 firm fixed-price delivery order contract has a performance period through May 20, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/18/25, 9:57 AM